Back

Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Diabetes and the heart 1 Metabolic Syndrome, Insulin, Insulin Resistance ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Diabetes and coronary risk equivalency - a population-based cohort study from Western Denmark
Doctor K. Olesen (Aarhus, DK)
Abstract Slides
Presentation thumbnail
Measures of insulin resistance as a screening tool for dysglycaemia in patients with coronary artery disease. A report from the EUROASPIRE V population.
Doctor G. Ferrannini (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Quantity of adipose tissue and adipose tissue dysfunction and the risk of cancer in individuals at high risk of cardiovascular disease
Ms M. Helmink (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Metabolic syndrome and heart failure: 40 years follow up results of the Seven Countries Study
Assistant Professor B. Parapid (Belgrade, RS)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources